| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6115280 | Current Opinion in Immunology | 2013 | 8 Pages |
Abstract
⺠Current tumor immunotherapy may be improved by integrating with material-based strategies. ⺠Material-based vaccines induce strong immune responses and tumor regression. ⺠Material platforms can interact with and direct immune cells to exert antitumor functions. ⺠Particle vaccines can target and manipulate organs, cells and subcellular compartments.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Weiwei Aileen Li, David J Mooney,